611-P: Effect of Continuous Glucose Monitoring (CGM) vs. Blood Glucose Monitoring (BGM) during a Nutrition Intervention on Time in Range (TIR)
Introduction: Reducing carbohydrate intake improves glycemia in people with T2D. Data on nutrition interventions using CGM are sparse. IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) compared differences in change in CGM-derived TIR (% time with glucose 70‑180 mg/dL) from baseli...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73 (Supplement_1), p.1 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction: Reducing carbohydrate intake improves glycemia in people with T2D. Data on nutrition interventions using CGM are sparse. IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) compared differences in change in CGM-derived TIR (% time with glucose 70‑180 mg/dL) from baseline (Base) to three months (M3) in people using CGM or BGM during a medically supervised ketogenic diet program (MSKDP) delivered via continuous remote care.
Methods: IGNITE (NCT05516797) randomized adults with T2D to CGM (N=81) or BGM (N=82). CGM and BGM data were used by participants and the care team to support dietary adherence and medication management decisions. Blinded CGM data at Base were compared to CGM data at M3 (blinded for BGM and cloud-based for CGM).
Results: At baseline, participants were (mean + SD) 53 + 10 years; 106 + 25 kg; 10 + 8 years with T2D; taking 2.2 + 1.0 diabetes medications, and HbA1c 8.1% + 1.2%, with no differences between arms. TIR improved (Base to M3) for both arms, 28% for CGM and 23% for BGM (p |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db24-611-P |